Drug
Methyldopa clinical trials
Also written Aldomet.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 1996
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2005 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 2 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 10
Federal University of Paraíba (1) · University of Colorado, Denver (1) · Vanderbilt University Medical Center (1) · University of British Columbia (1) · Gynuity Health Projects (1) · Isfahan University of Medical Sciences (1) · Maastricht University Medical Center (1) · Professor Fernando Figueira Integral Medicine Institute (1)
Often tested with
Tested in the same studies.
Labetalol (2) · Phenylephrine (1) · Isoproterenol (1) · Nitroprusside (1) · Propranolol (1) · Edrophonium (1) · Atropine (1) · Tyramine (1)
Studies
Open first, then newest update. How each study uses Methyldopa is read from its arms, and is right about nine times in ten.
Testing it · 10
- Management of Hypertension in the Early Postpartum: a Randomized Controlled TrialCompletedPhase 4Federal University of ParaíbaNCT04835233Written as Methyldopa 250 MG
- Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 DiabetesCompletedNot applicableUniversity of Colorado, DenverNCT01883804Written as Methyldopa
- The Pathophysiology of Orthostatic HypotensionCompletedPhase 1Vanderbilt University Medical CenterNCT00748059Written as clonidine,yohimbine,metoclopramide,alpha-methyldopa
- Early Vascular Adjustments During Hypertensive PregnancyStatus unknownPhase 4Maastricht University Medical CenterNCT02531490Written as Methyldopa
- Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 DiabetesWithdrawnPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03396484Written as Methyldopa
- Community Level Interventions for Pre-eclampsiaCompletedNot applicableUniversity of British ColumbiaNCT01911494Written as Methyldopa
- Oral Antihypertensive Regimens for Management of Hypertension in PregnancyCompletedPhase 4Gynuity Health ProjectsNCT01912677Written as Methyldopa
- Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild PreeclampsiaCompletedPhase 2Isfahan University of Medical SciencesNCT01674127Written as Methyldopa
- Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)Status unknownPhase 4Professor Fernando Figueira Integral Medicine InstituteNCT01361425Written as methildopa
- Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsiaStatus unknownPhase 4Radboud University Medical CenterNCT00117546Written as alpha methyldopa
Given in every arm · 1 — Methyldopa is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Methyldopa
Codes
What other systems call Methyldopa · ClinicalTrials.gg INT007815
- MeSH (NLM) D008750MethyldopaConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 56LH93261YMETHYLDOPAConfirmed FDA, NLM, Wikidata
- RxNorm 6876One source FDA
- Wikidata Q72490376L-MethyldopaConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47616MethyldopaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008750 | Methyldopa | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 56LH93261Y | METHYLDOPA | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6876 | — | One source FDA |
| Wikidata | Q72490376 | L-Methyldopa | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47616 | Methyldopa | One source FDA |
Also registered as methyldopate (UNII 2579Z4P04J · RxNorm 6877).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.